Arsanis Biosciences GmbH

Arsanis is a biotechnology company dedicated to the development of human antibody based therapeutics against severe infectious diseases.

Arsanis is developing a pipeline of monoclonal antibody programs targeting infectious diseases where current approaches are either ineffective or non-existent.

Since its founding in 2010, Arsanis has emerged as a leader in the field of antibody based anti-infectives.